Averywell
1 known investors
Averywell develops a non-invasive, miRNA-based liquid blood test for early lung cancer detection and lung nodule management, using AI and machine learning to analyze microRNA profiles. The test targets both smokers and non-smokers as an at-risk screening population.
Investors · 1
Frequently asked questions
- What does Averywell do?
- Averywell develops a non-invasive, miRNA-based liquid blood test for early lung cancer detection and lung nodule management, using AI and machine learning to analyze microRNA profiles. The test targets both smokers and non-smokers as an at-risk screening population.
- Who are Averywell's investors?
- Averywell's investors include Genesis Ventures.